The Myositis Therapy Diaries
Rituximab is actually a chimeric monoclonal antibody versus the CD20 antigen expressed about the floor of B lymphocytes resulting in their depletion in the peripheral blood. a number of case stories, situation series and open-label trials have prompt a helpful influence of rituximab in sufferers with refractory myositis (current overview in explora